TSMC’s results (TSM.US) have reignited Wall Street’s appetite for semiconductor stocks, lifting shares of Nvidia, Broadcom, and less headline-grabbin, but still very large names such as Lam Research (LRCX.US) and Applied Materials (AMAT.US). With revenue at the world’s largest chipmaker growing at a 35% y/y pace, the market is increasingly willing to price in a scenario where further AI-driven investment looks “almost inevitable.”
- This dynamic leads to two parallel narratives. The first is a reassessment of just how large the demand uplift could be across the broader semiconductor complex. The second is investors’ growing willingness to pay—often at record valuations for exposure to companies benefiting from the rally, as seen in memory-boom beneficiaries such as KLA Corp. (KLAC.US).
- KLA shares are rising to fresh all-time highs today. Major US financial institutions have raised their price targets for the stock, including Morgan Stanley and Wells Fargo, while Barclays also delivered a positive view. RBC Capital has initiated coverage of the company.
iShares MSCI Global Semiconductors ETF (SEC0.DE), D1 interval
Since April 5, 2025 (the tariff-related sell-off triggered by Trump’s reciprocal duties), the broad index of global semiconductor stocks has surged by roughly 120%.

Source: xStation5
KLA Corp riding the semiconductor bull market
In recent days, KLA Corp. has been one of Wall Street’s standout leaders. The company operates in semiconductor metrology and process control, and it has now moved into the spotlight of the world’s largest financial institutions.
- A wave of upgrades and higher price targets suggests Wall Street increasingly views KLA as one of the biggest potential winners of the next leg of investment in AI infrastructure. The key catalyst has been a shift in the narrative around the memory market (DRAM and NAND), which analysts argue is becoming a critical bottleneck for AI—nearly as important as GPUs and advanced processors themselves.
- The strongest signal came from Morgan Stanley, which upgraded KLA to overweight from equal-weight. The bank argues that the market is still underpricing the company’s exposure to the memory segment, which is returning to the spotlight as AI-driven demand accelerates.
Memory chips are becoming a key constraint on AI’s expansion. In practice, this means that as AI investment grows, it’s not enough to produce more compute chips—massive volumes of modern memory are also required, and performance requirements are rising just as quickly.
In this context, Morgan Stanley points to rising process-control intensity across both DRAM and NAND. The more complex the manufacturing process and the tighter the quality requirements, the more valuable KLA’s tools become—helping fabs reduce defects and improve yield. Morgan Stanley simultaneously lifted its price target for KLAC to $1,697 from $1,214, one of the highest projections among major institutions.
Wells Fargo joins in
Wells Fargo quickly followed, also upgrading KLA from equal-weight to overweight, while raising its price target from $1,250 to $1,600. The move can be read as a confirmation that the market is entering a phase where it’s not just “AI hype” that matters, but tangible capital spending: expanding capacity, modernizing processes, and pushing manufacturing toward more advanced nodes.
In this cycle, companies like KLA occupy a particularly strategic position in the value chain: without process control and metrology, it’s difficult to scale advanced semiconductor production at the quality levels the market demands.
Barclays: AI remains the key driver into 2026—and KLA is a pillar of the theme
Barclays also took a strong stance, raising its price target on KLA to $1,595 from $1,300, while maintaining an overweight rating. According to Barclays, 2026 is set to be another year in which:
-
proximity to the AI theme will be the dominant factor for semiconductor stock performance, and
-
investors will favor companies that are “central to the pillars of AI.”
Barclays highlights an increasingly important market reality: at some point, the narrative of “AI is growing” stops being sufficient, and the key question becomes how much of the opportunity can actually be implemented and monetized in the real economy. In such an environment, investors may prefer companies that aren’t just theoretical beneficiaries, but are genuinely essential to the semiconductor ecosystem. KLA fits that definition by supporting a critical part of the manufacturing process.
KLA Corp (KLAC.US) chart, D1

Source: xStation5
KLA is delivering a solid improvement in profitability and record-high revenues, but it’s hard to argue that this hasn’t come alongside richer valuations. The stock’s price-to-forward 12-month earnings multiple is already around 41, well above the Nasdaq 100 average, while the current P/E is close to 45. The price-to-sales ratio is also at historically elevated levels (though it was even higher at points in 2025). Return on invested capital (ROIC) has been rising since the second half of 2024, although it was higher in 2021–2022. At the same time, the company’s cost of capital (WACC) remains well below ROIC, implying that KLA is still generating real value for shareholders.

Source: XTB Research, Bloomberg Finance L.P.

Source: XTB Research, Bloomberg Finance L.P.
Experimental drug suspendedโ๐ Shares od Disc Medicine lose as much as 7% ๐จ
Divorce of Europe and the USA over Greenland
US Open: Optimism drives indices on Wall Street๐BlackRock surges after earnings
JP Morgan and Goldman Sachs: Giants after earnings
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.